According to the optimized RVG mRNA provided by the invention, a
rabies virus CTN-1 strain
G protein (RVG)
coding region is optimized, and the optimization comprises the following steps: adjusting codon preference during expression in a
human body, adjusting the use frequency of common codons, improving the
GC content of the sequence and the like, so that the obtained
nucleotide sequence transcribed mRNA is more stable in structure, more stable in expression, and more stable in expression. And the translation efficiency of the
target protein in mammals and human bodies is higher. And mixing the vaccine vector with the optimized RVG mRNA to obtain the
rabies virus nucleic acid vaccine. The method is simple and easy to operate, the process difficulty of
vaccine production is reduced, large-scale production can be realized, the batch difference is easy to control, and the production cost is greatly reduced. Enough protection effect can be achieved by using an extremely small dosage, the production cost is reduced, and the
rabies vaccine is superior to the existing
rabies vaccine in the aspect of effectiveness.